- Filed
- Feb 23, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Feb 23, 2026 | 222.37M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 182.24M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 162.79M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2024 | 128.96M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2024 | 128.94M sh |
| Capex | Q2 2026 · Dec 31, 2025 | $65.36K |
| Capex | Q2 2026 · Dec 31, 2024 | $39.7K |
| Operating Cash Flow | Q2 2026 · Dec 31, 2025 | −$3.92M |
| Operating Cash Flow | Q2 2026 · Dec 31, 2024 | −$270.24K |
| Long Term Debt | Q2 2026 · Dec 31, 2025 | $19.01M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $86.37M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | −$17.88M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | −$17.33M |
| Stockholders Equity | Q2 2026 · Mar 25, 2025 | $40M |
| Stockholders Equity restated | Q2 2026 · Dec 31, 2024 | −$10.72M |
| Stockholders Equity restated | Q2 2026 · Sep 30, 2024 | −$10.25M |
| Stockholders Equity restated | Q2 2026 · Jun 30, 2024 | −$9.47M |
| Current Liabilities | Q2 2026 · Dec 31, 2025 | $21.75M |
| Current Liabilities | Q2 2026 · Jun 30, 2025 | $11.47M |
| Total Liabilities | Q2 2026 · Dec 31, 2025 | $43.24M |
| Total Liabilities | Q2 2026 · Jun 30, 2025 | $11.95M |
| Current Assets | Q2 2026 · Dec 31, 2025 | $1.65M |
| Current Assets | Q2 2026 · Jun 30, 2025 | $777.47K |
| Total Assets | Q2 2026 · Dec 31, 2025 | $129.62M |
| Total Assets | Q2 2026 · Jun 30, 2025 | $7.32M |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | −$0.02 |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | −$0.05 |
| Eps Diluted restated | Q2 2026 · Dec 31, 2024 | $0.00 |
| Eps Diluted | Q2 2026 · Dec 31, 2024 | −$0.01 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | −$0.02 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | −$0.05 |
| Eps Basic restated | Q2 2026 · Dec 31, 2024 | $0.00 |
| Eps Basic | Q2 2026 · Dec 31, 2024 | −$0.01 |
| Net Income | Q2 2026 · Dec 31, 2025 | −$4.29M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$7.98M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$3.7M |
| Net Income restated | Q2 2026 · Dec 31, 2024 | −$479.61K |
| Net Income | Q2 2026 · Dec 31, 2024 | −$1.24M |
| Net Income | Q2 2026 · Sep 30, 2024 | −$764.61K |
| Operating Income | Q2 2026 · Dec 31, 2025 | −$3.52M |
| Operating Income | Q2 2026 · Dec 31, 2025 | −$5.69M |
| Operating Income restated | Q2 2026 · Dec 31, 2024 | −$191.85K |
| Operating Income restated | Q2 2026 · Dec 31, 2024 | −$410.31K |
| Cost Of Revenue | Q2 2026 · Dec 31, 2025 | $774.49K |
| Cost Of Revenue | Q2 2026 · Dec 31, 2025 | $1.25M |
| Revenue | Q2 2026 · Dec 31, 2025 | $2.21M |
| Revenue | Q2 2026 · Dec 31, 2025 | $2.97M |